Trial intelligence / Profile preview

Topical propranolol gel for superficial infantile hemangioma (0%, 1%, 5%)

jRCTs031180234Completed

Sponsor
Chiba Rosai Hospital
Start
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of propranolol in Capillary Haemangioma (3 arms), sponsored by Chiba Rosai Hospital. Primary endpoint: Change rate of tumor color tone. Started Oct 2015; status: completed.

02

Drugs

propranolol
03

Conditions

Capillary Haemangioma

Beyond the preview

Go deeper on jRCTs031180234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031180234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call